Skip to content

Lifestyle recommendations

OTHER8 trials

Sponsors

Pauls Stradins Clinical University Hospital, Barcelonabeta Brain Research Center, Pasqual Maragall Foundation, National University of Natural Medicine, Ataturk Training and Research Hospital, Ankara Yildirim Beyazıt University

Conditions

Alzheimer's DiseaseAtherosclerosisCoronary Artery DiseaseDietFitness TestingHealthyHypertensionLifestyle

Phase 4

Unknown Phase

Control and Intervention Programme on Alzheimer's Disease Risk Factors
CompletedNCT02772523
Barcelonabeta Brain Research Center, Pasqual Maragall FoundationAlzheimer's Disease
Start: 2016-05-31End: 2019-05-31Updated: 2020-07-21
Methylation Diet and Lifestyle Study
Active, not recruitingNCT03472820
National University of Natural MedicineDiet, Healthy, Lifestyle
Start: 2018-02-01End: 2024-12-31Updated: 2024-08-06
Effects of Digital Pelvic Floor Muscle Training in Patients With Multiple Sclerosis Having Lower Urinary Tract Symptoms
NCT04759391
Ataturk Training and Research HospitalLower Urinary Tract Symptoms
Start: 2021-02-28End: 2021-07-31Target: 30Updated: 2021-02-18
Effects of Spinal Stabilization Exercises Focusing on the Pelvic Floor in Women With Overactive Bladder
CompletedNCT05677841
Ankara Yildirim Beyazıt UniversityOveractive Bladder
Start: 2023-01-15End: 2023-05-25Updated: 2023-07-19
Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension.
RecruitingNCT06823570
Heinrich-Heine University, DuesseldorfFitness Testing, Hypertension, Metabolism Changes +1
Start: 2025-04-01End: 2028-12-31Target: 60Updated: 2025-03-12
Online Pain Neuroscience Education for Women With Primary Dysmenorrhea
CompletedNCT07237802
Cardenal Herrera UniversityPrimary Dysmenorrhea (PD)
Start: 2025-09-01End: 2026-02-28Updated: 2026-04-17
Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
Not yet recruitingNCT07609160
Acibadem UniversityObesity, Overweight (Without Type 2 Diabetes) With Weight-related Comorbidities, Sarcopenia
Start: 2026-11-01End: 2028-01-01Target: 108Updated: 2026-06-04